Market Research Logo

Dermal Filler - Medical Devices Pipeline Assessment, 2018

Dermal Filler - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Dermal Filler - Medical Devices Pipeline Assessment, 2018 provides an overview of Dermal Filler currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Dermal Filler pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Dermal Filler under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Dermal Filler and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Dermal Filler under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Dermal Filler Overview
3 Products under Development
3.1 Dermal Filler - Pipeline Products by Stage of Development
3.2 Dermal Filler - Pipeline Products by Territory
3.3 Dermal Filler - Pipeline Products by Regulatory Path
3.4 Dermal Filler - Pipeline Products by Estimated Approval Date
4 Dermal Filler - Pipeline Products under Development by Companies
4.1 Dermal Filler Companies - Pipeline Products by Stage of Development
4.2 Dermal Filler - Pipeline Products by Stage of Development
5 Dermal Filler Companies and Product Overview
5.1 Aeon Astron Corporation Company Overview
5.2 Allergan Inc Company Overview
5.3 Allergan Plc Company Overview
5.4 Almirall Ltd Company Overview
5.5 Anika Therapeutics Inc Company Overview
5.6 Bioxis Pharmaceuticals Company Overview
5.7 Celltrix AB Company Overview
5.8 CollPlant Ltd Company Overview
5.9 Dermele Skin Care, LLC Company Overview
5.10 EternoGen Aesthetics LLC Company Overview
5.11 Genzyme Corp Company Overview
5.12 Innovia LLC Company Overview
5.13 Juvenis Ltd Company Overview
5.14 Khorionyx SA Company Overview
5.15 Moma Therapeutics, Inc. Company Overview
5.16 N8 Medical Inc Company Overview
5.17 Oligo Medic Inc Company Overview
5.18 PetVivo Holdings Inc Company Overview
5.19 Regenscientific Company Overview
5.20 Samyang Biopharmaceuticals Corp Company Overview
5.21 Sekisui Medical Co Ltd Company Overview
5.22 Shanghai Haohai Biological Technology Co Ltd Company Overview
5.23 Shin Poong PharmCo Ltd Company Overview
5.24 Sinclair Pharma PLC Company Overview
5.25 Sofregen Medical Inc Company Overview
5.26 TEI Biosciences Inc Company Overview
5.27 University of California Santa Barbara Company Overview
6 Dermal Filler- Recent Developments
6.1 Jul 05, 2018: Sinclair Pharma: Trading Update for the 6 months to 30 June 2018
6.2 Jun 04, 2018: SWAG Penis Enhancement Procedure Developed by Top Plastic Surgeon Achieving Optimal Results
6.3 May 21, 2018: Nestle Skin Health Announces the FDA Approval of Restylane Lyft for Hands, the First and Only Hyaluronic Acid (HA) Dermal Filler for Use in the Back of Hands
6.4 May 15, 2018: BTG: Final Results For year ended 31 March 2018
6.5 May 09, 2018: FibroGen Reports First Quarter 2018 Financial Results
6.6 May 08, 2018: Smith & Nephew: Change of Directorate
6.7 May 08, 2018: CollPlant Files U.S. Patent Application for Next Generation Dermal Filler
6.8 May 03, 2018: Smith & Nephew First Quarter 2018 Trading Report
6.9 May 02, 2018: Anika Reports First Quarter 2018 Financial Results
6.10 Apr 30, 2018: Sinclair Pharma: Preliminary results for 12 months ended 31 December 2017
6.11 Apr 30, 2018: Sinclair secures €23 million debt facility
6.12 Apr 09, 2018: Merz Aesthetics Launches New Belotero Lips Dermal Filler Products
6.13 Apr 04, 2018: Namal Nawana appointed Chief Executive Officer of Smith & Nephew
6.14 Mar 20, 2018: Governor Abbott Announces Smith & Nephew Adding New Jobs In Fort Worth
6.15 Mar 05, 2018: Anika Therapeutics Names Joseph Darling As CEO And Director
6.16 Mar 01, 2018: Smith & Nephew: Change in Directorate
6.17 Feb 27, 2018: FibroGen Announces Fourth Quarter and Full Year 2017 Financial Results
6.18 Feb 21, 2018: Anika Announces Fourth Quarter and Full Year 2017 Financial Results
6.19 Feb 16, 2018: Merz North America to Highlight Treatments at American Academy of Dermatology Annual Meeting
6.20 Feb 08, 2018: Smith & Nephew Fourth Quarter Trading and Full Year 2017 Results
6.21 Jan 31, 2018: Smith & Nephew Appoints Roland Diggelmann As Non-Executive Director
6.22 Jan 31, 2018: Appointment of Roland Diggelmann as Non-Executive Director
6.23 Jan 16, 2018: Galderma Introduces Restylane Skinboosters
6.24 Jan 16, 2018: Sinclair Pharma: Ellanse Approved for Brazil
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Dermal Filler - Pipeline Products by Stage of Development
Table 2: Dermal Filler - Pipeline Products by Territory
Table 3: Dermal Filler - Pipeline Products by Regulatory Path
Table 4: Dermal Filler - Pipeline Products by Estimated Approval Date
Table 5: Dermal Filler Companies - Pipeline Products by Stage of Development
Table 6: Dermal Filler - Pipeline Products by Stage of Development
Table 7: Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 8: BioDermal Filler - Product Status
Table 9: BioDermal Filler - Product Description
Table 10: Allergan Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 11: JUVEDERM Volbella - Product Status
Table 12: JUVEDERM Volbella - Product Description
Table 13: VYC-25L Hyaluronic Acid Injectable Gel - Product Status
Table 14: VYC-25L Hyaluronic Acid Injectable Gel - Product Description
Table 15: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 16: HA Threads - Product Status
Table 17: HA Threads - Product Description
Table 18: Juvederm Volift - Nasolabial Folds - Product Status
Table 19: Juvederm Volift - Nasolabial Folds - Product Description
Table 20: Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Hyaluronic Acid Facial Filler - Product Status
Table 22: Hyaluronic Acid Facial Filler - Product Description
Table 23: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Next Generation ELEVESS Dermal Filler - Product Status
Table 25: Next Generation ELEVESS Dermal Filler - Product Description
Table 26: Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview
Table 27: CYTOSIAL Deep Wrinkle - Product Status
Table 28: CYTOSIAL Deep Wrinkle - Product Description
Table 29: CYTOSIAL Medium - Product Status
Table 30: CYTOSIAL Medium - Product Description
Table 31: Cytosial Volume - Product Status
Table 32: Cytosial Volume - Product Description
Table 33: Cytosmile - Product Status
Table 34: Cytosmile - Product Description
Table 35: MTI-12 - Aesthetic Device - Product Status
Table 36: MTI-12 - Aesthetic Device - Product Description
Table 37: MTI-12 - Surgical Repair - Product Status
Table 38: MTI-12 - Surgical Repair - Product Description
Table 39: Celltrix AB Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Credurance - Product Status
Table 41: Credurance - Product Description
Table 42: CollPlant Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 43: Next Generation Dermal Filler - Product Status
Table 44: Next Generation Dermal Filler - Product Description
Table 45: Dermele Skin Care, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Gold Nanoparticle Dermal Filler - Product Status
Table 47: Gold Nanoparticle Dermal Filler - Product Description
Table 48: EternoGen Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 49: Cellifique - Product Status
Table 50: Cellifique - Product Description
Table 51: Genzyme Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 52: Dermal Gel Extra - Product Status
Table 53: Dermal Gel Extra - Product Description
Table 54: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 55: Wrinkle Filler - Product Status
Table 56: Wrinkle Filler - Product Description
Table 57: Juvenis Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 58: Tenergel - Product Status
Table 59: Tenergel - Product Description
Table 60: Khorionyx SA Pipeline Products & Ongoing Clinical Trials Overview
Table 61: Autologous Globin Dermal Filler - Product Status
Table 62: Autologous Globin Dermal Filler - Product Description
Table 63: Moma Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 64: Restogel-131 - Product Status
Table 65: Restogel-131 - Product Description
Table 66: N8 Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 67: Ceragenin-Infused Dermal Filler - Product Status
Table 68: Ceragenin-Infused Dermal Filler - Product Description
Table 69: Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 70: AntaRep - Product Status
Table 71: AntaRep - Product Description
Table 72: PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 73: Dermal Filler - Product Status
Table 74: Dermal Filler - Product Description
Table 75: Dermal Filler - Lip - Product Status
Table 76: Dermal Filler - Lip - Product Description
Table 77: Regenscientific Pipeline Products & Ongoing Clinical Trials Overview
Table 78: Renu Soft Tissue Volumizing Filler - Aesthetic - Product Status
Table 79: Renu Soft Tissue Volumizing Filler - Aesthetic - Product Description
Table 80: Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 81: Aesthetic Filler - Product Status
Table 82: Aesthetic Filler - Product Description
Table 83: Sekisui Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 84: NADGL - Product Status
Table 85: NADGL - Product Description
Table 86: Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 87: QST Gel - Product Status
Table 88: QST Gel - Product Description
Table 89: Third Generation Matrifill - Product Status
Table 90: Third Generation Matrifill - Product Description
Table 91: Shin Poong PharmCo Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 92: FreeWink - Product Status
Table 93: FreeWink - Product Description
Table 94: Sinclair Pharma PLC Pipeline Products & Ongoing Clinical Trials Overview
Table 95: Atlean - Product Status
Table 96: Atlean - Product Description
Table 97: Ellansé Lidocaine - Product Status
Table 98: Ellansé Lidocaine - Product Description
Table 99: Ellansé-E - Product Status
Table 100: Ellansé-E - Product Description
Table 101: Ellansé-L - Product Status
Table 102: Ellansé-L - Product Description
Table 103: Ellansé-M - Product Status
Table 104: Ellansé-M - Product Description
Table 105: Ellansé-S - Product Status
Table 106: Ellansé-S - Product Description
Table 107: Perfectha G - Product Status
Table 108: Perfectha G - Product Description
Table 109: Perfectha Lidocaine - Product Status
Table 110: Perfectha Lidocaine - Product Description
Table 111: Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 112: Silk Protein - Tissue/Dermal Filler - Product Status
Table 113: Silk Protein - Tissue/Dermal Filler - Product Description
Table 114: TEI Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 115: Injectable Dermal Filler - Product Status
Table 116: Injectable Dermal Filler - Product Description
Table 117: University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview
Table 118: Needle Free Injector - Product Status
Table 119: Needle Free Injector - Product Description
Table 120: Glossary
1.2 List of Figures
Figure 1: Dermal Filler - Pipeline Products by Stage of Development
Figure 2: Dermal Filler - Pipeline Products by Territory
Figure 3: Dermal Filler - Pipeline Products by Regulatory Path
Figure 4: Dermal Filler - Pipeline Products by Estimated Approval Date

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report